Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Companyâs multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļIKT
āļāļ·āđāļāļāļĢāļīāļĐāļąāļInhibikase Therapeutics Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 23, 2020
āļāļĩāļāļĩāđāļIwicki (Mark T)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ15
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļDec 23
āļāļĩāđāļāļĒāļđāđ1000 N. West Street, Suite 1200
āđāļĄāļ·āļāļWILMINGTON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ19801
āđāļāļĢāļĻāļąāļāļāđ13022953800
āđāļ§āđāļāđāļāļāđhttps://www.inhibikase.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļIKT
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 23, 2020
āļāļĩāļāļĩāđāļIwicki (Mark T)
Dr. Christopher H. (Chris) Cabell, M.D.
Dr. Christopher H. (Chris) Cabell, M.D.
President, Head - Research and Development
President, Head - Research and Development
Mr. Vincent E. (Vince) Aurentz
Mr. Vincent E. (Vince) Aurentz
Independent Director
Mr. Amit D. Munshi
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Arvind Kush
Independent Director
Mr. Dennis N. Berman
Independent Director
Dr. Roy Freeman, M.D.
Independent Director
Mr. Roberto Bellini
Independent Director
Mr. David Canner, Ph.D.
Independent Director
Mr. Mike Moyer
Managing Director of LifeSci Advisors
Managing Director of LifeSci Advisors
Mr. Mark T. Iwicki
Chief Executive Officer, Director
Chief Executive Officer, Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. Christopher H. (Chris) Cabell, M.D.
Dr. Christopher H. (Chris) Cabell, M.D.
President, Head - Research and Development
President, Head - Research and Development
Mr. Vincent E. (Vince) Aurentz
Mr. Vincent E. (Vince) Aurentz
Independent Director
Mr. Amit D. Munshi
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Arvind Kush
Independent Director
Mr. Dennis N. Berman
Independent Director
Dr. Roy Freeman, M.D.
Independent Director